Overview of Cellular Immunotherapy for Patients with Glioblastoma
High grade gliomas (HGG) including glioblastomas (GBM) are the most common and devastating primary brain tumours. Despite important progresses in GBM treatment that currently includes surgery combined to radio- and chemotherapy, GBM patients' prognosis remains very poor. Immunotherapy is one of...
Saved in:
| Main Authors: | Elodie Vauleon, Tony Avril, Brigitte Collet, Jean Mosser, Véronique Quillien |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2010/689171 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme
by: Xun Xu, et al.
Published: (2012-01-01) -
Immunotherapy in Glioblastoma: An Overview of Current Status
by: Sarfraz Z, et al.
Published: (2025-07-01) -
Dual IRE1 RNase functions dictate glioblastoma development
by: Stéphanie Lhomond, et al.
Published: (2018-01-01) -
Advances in Immunotherapy for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2017-01-01) -
MicroRNA in Glioblastoma: An Overview
by: Barbara Banelli, et al.
Published: (2017-01-01)